Artificial Pancreas Device System Market

Global Artificial
Pancreas Device
System Market
Share, Global Trends,
Analysis, Research, Report,
Opportunities,
Segmentation and Forecast,
2015
Future Market Insights
www.futuremarketinsights.com
sales@futuremarketinsights.com

Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,
technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and
Retail.
We have a global presence with delivery centers across India specializing in providing global research reports and country
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.
We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for
our client.
Research Capabilities
• Customized Research
• Syndicated Research
• Investment Research
• Social Media Research
Sector Coverage
• Automotive and Transportation
• Electronics, Semiconductor, and ICT
• Retail and Consumer Products
• Industrial Automation and Equipment
• Chemicals & Materials
• Food and Beverages
• Services and Utilities
• Energy, Mining, Oil, and Gas
Customized
Research
Syndicated
Research
Investment
Research
Social Media
Research
Subscription Information
For detailed subscription information please contact
Hari. T (Sr. Manager - Global Business Development)
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
Email: hari.t@futuremarketinsights.com

Report Description
Pancreas is one of the major endocrine gland which secretes hormones released directly
into the blood. Pancreas is around 6 inches long located in the abdominal cavity. Pancreas
produce the vital hormones of insulin, pancreatic polypeptide, glucagon and
somatostatin. Pancreas aid in digestion and absorption processes by secreting the
pancreatic juice which contains digestive enzymes. The Artificial Pancreas Device System
is used in the treatment of Type 1 Diabetes. Type 1 diabetes patients require multiple
doses of insulin in a day and all-round the year. The Artificial Pancreas Device System is
also referred to as the closed-loop system or autonomous system for glycemic control or
bionic pancreas. The Artificial Pancreas Device System simulates the glucose regulation
function of a healthy pancreas. The continuous glucose monitoring is done by placing the
sensor subcutaneously to measure the glucose level in the fluid around the cells. A
transmitter sends information of glucose level estimates and their rate of change to the
receiver. Control algorithm software embedded in an external controller performs
mathematical calculations to send dosing instruction to the insulin infusion pumps,
computer or smartphone. Depending on the dosing instructions, the insulin infusion
pump regulates the level of insulin delivery to the subcutaneous tissue.
Browse Full Report@ http://www.futuremarketinsights.com/reports/artificial-pancreasdevice-system-market
Artificial Pancreas Device System Market: Drivers & Restraints
The Food and Drug Administration (FDA) is collaborating with private and government
research institutions to improvise clinical studies and accelerate the development of the

Report Description
the FDA released a document on requirements of clinical studies and premarket approval
applications for the production Artificial Pancreas Device Systems. This will encourage the
manufacturing of Artificial Pancreas Device Systems and drive the growth of the global
Artificial Pancreas Device System market. The patients need to calibrate the continuous
glucose monitor at equal intervals. Also, the continuous glucose monitoring sensors are
subjected to biofouling and fibrosis when they are placed subcutaneously which alters
the productivity of sensors. The FDA has identified issues in the components and
software of insulin infusion pumps. The insulin used currently in the Artificial Pancreas
Device Systems takes longer duration of time to completely absorb. Such factors related
to Artificial Pancreas Device Systems could potentially hamper the growth of the global
Artificial Pancreas Device Systems market.
Artificial Pancreas Device System Market: Segmentation
Artificial Pancreas Device System market is classified on the basis product type and
geography.
Based on product type, the global Artificial Pancreas Device System market is segmented
into the following:
Threshold Suspend Device System
Control-to-Range (CTR) System
Control -to-Target (CTT) System

Report Description
Artificial Pancreas Device System Market: Overview
The concentration of glucose in the blood of the patient is very dynamic and is affected
by the patient’s physical activity and diet. The Artificial Pancreas Device System helps in
the sustenance of life of type 1 diabetes patients. The Artificial Pancreas Device System
does the function of beta cells of a healthy pancreas. Type 1 diabetes patient have to
closely monitor blood glucose levels in order to avoid hyperglycemia and hypoglycemia
which leads to long-term diabetes complications such as seizures, coma and even death.
Thus, blood glucose monitoring on a daily basis is essential and the Artificial Pancreas
Device System is the solution to it.
Request Report Sample with TOC@
http://www.futuremarketinsights.com/reports/sample/rep-gb-974
Artificial Pancreas Device System Market: Region-wise Outlook
Depending on geographic regions, global Artificial Pancreas Device System market is
segmented into seven key regions: North America, South America, Eastern Europe,
Western Europe, Asia Pacific Excluding Japan, Japan, and Middle East & Africa. India,
China, USA, Indonesia, Pakistan and Japan are the top six countries with the highest
number of estimated cases of diabetes. As a result, Asia Pacific and North America are
anticipated to be the potential markets for the global Artificial Pancreas Device System
market players.

Report Description
Artificial Pancreas Device System Market: Key Players
Some of the key market players in global Artificial Pancreas Device System market are
Pancreum, LLC, Medtronic, Inc. and JDRF. In the near future, the global Artificial Pancreas
Device System manufacturers have to develop products which will not only monitor but
also adjust the blood glucose levels rapidly without the need of intervention of the
patient.

Thank You!
To know more about us, please visit our website:
www.futuremarketinsights.com
For sales queries or new topics email us on:
sales@futuremarketinsights.com
For other queries contact: Mr. Sudip Saha
Future Market Insights: 616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
T: +1-347-918-3531 | D: +1-845-579-5705